Carl Zeiss Meditec AG

AFX: XETR (DEU)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LlLOCK|%Z^SLOCK|@XBh#FY

Carl Zeiss Earnings: Lowering FVE From Market Challenges, Soft Guidance, and Long Transition Period

Carl Zeiss delivered 8.3% and 6.5% revenue and adjusted EPS growth, respectively, during its fourth fiscal quarter. Shares are down roughly 6% following the readout Dec. 11.

Sponsor Center